Exploration of Piperidinols as Potential Antitubercular Agents
Novel drugs to treat tuberculosis are required and the identification of potential targets is important. Piperidinols have been identified as potential antimycobacterial agents (MIC < 5 μg/mL), which also inhibit mycobacterial arylamine N-acetyltransferase (NAT), an enzyme essential for mycob...
Main Authors: | Areej Abuhammad, Elizabeth Fullam, Sanjib Bhakta, Angela J. Russell, Garrett M. Morris, Paul W. Finn, Edith Sim |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2014-10-01
|
Series: | Molecules |
Subjects: | |
Online Access: | http://www.mdpi.com/1420-3049/19/10/16274 |
Similar Items
-
3-(5-Nitrofuran-2-yl)prop-2-en-1-one Derivatives, with Potent Antituberculosis Activity, Inhibit A Novel Therapeutic Target, Arylamine <i>N</i>-acetyltransferase, in Mycobacteria
by: Neha Agre, et al.
Published: (2020-07-01) -
Structure‐Based Design and Synthesis of Piperidinol‐Containing Molecules as New Mycobacterium abscessus Inhibitors
by: Dr. Jérôme deRuyck, et al.
Published: (2020-03-01) -
Trimodal distribution of arylamine N-acetyltransferase 1 mRNA in breast cancer tumors: association with overall survival and drug resistance
by: Rodney F. Minchin, et al.
Published: (2018-07-01) -
NAT2 gene polymorphism in bladder cancer: a study from North India
by: Rama D. Mittal, et al.
Published: (2004-08-01) -
<i>N</i>-(6-Chloro-3-nitropyridin-2-yl)-5-(1-methyl-1<i>H</i>-pyrazol-4-yl)isoquinolin-3-amine
by: Valentin Wydra, et al.
Published: (2021-01-01)